One study demonstrates previously that MALAT1 associates with PRC2 by interacting with SUZ12 but not EZH2 and that inhibition of MALAT1 decreases the binding of SUZ12 to the E-cadherin gene promoter in bladder cancer [18]. The gene discussed is EZH2; the disease is urinary bladder carcinoma.